Pharmacist intervention to improve medication adherence in heart failure: A randomized trial

Michael Murray, James Young, Shawn Hoke, Wanzhu Tu, Michael Weiner, Daniel Morrow, Kevin T. Stroupe, Jingwei Wu, Daniel Clark, Faye Smith, Irmina Gradus-Pizlo, Morris Weinberger, D. Craig Brater

Research output: Contribution to journalArticle

309 Citations (Scopus)

Abstract

Background: Patients with heart failure who take several prescription medications sometimes have poor adherence to their treatment regimens. Few interventions designed to improve adherence to therapy have been rigorously tested. Objective: To determine whether a pharmacist intervention improves medication adherence and health outcomes compared with usual care for low-income patients with heart failure. Design: Randomized, controlled trial conducted from February 2001 to June 2004. Setting: University-affiliated, inner-city, ambulatory care practice. Patients: 314 low-income patients 50 years of age or older with heart failure confirmed by their primary care physician. Intervention: Patients were randomly assigned to intervention (39% [n = 122]) or usual care (61% [n = 192]) groups and were followed for 12 months. A pharmacist provided a 9-month multi-level intervention, with a 3-month poststudy phase. An interdisciplinary team of investigators designed the intervention to support medication management by patients who have low health literacy and limited resources. Measurements: Primary outcomes were adherence, as measured by using electronic prescription monitors, and exacerbations requiring emergency department care or hospital admission. Secondary outcomes included health-related quality of life, patient satisfaction with pharmacy services, and total direct costs. Results: During the 9-month intervention period, medication adherence was 67.9% and 78.8% in the usual care and intervention groups, respectively (difference, 10.9 percentage points [95% CI, 5.0 to 16.7 percentage points]). However, these salutary effects dissipated in the 3-month postintervention follow-up period, in which adherence was 66.7% and 70.6%, respectively (difference, 3.9 percentage points [CI, -5.9 to 6.5 percentage points]). Medications were taken on schedule 47.2% of the time in the usual care group and 53.1% of the time in the intervention group (difference, 5.9 percentage points [CI, 0.4 to 11.5 percentage points]), but this effect also dissipated at the end of the intervention (48.9% vs. 48.6%, respectively; difference, 0.3 percentage point [CI, -5.9 to 6.5 percentage points]). Emergency department visits and hospital admissions were 19.4% less (incidence rate ratio, 0.82 [CI, 0.73 to 0.93]) and annual direct health care costs were lower ($-2960 [CI, $-7603 to $1338]) in the intervention group. Limitations: Because electronic monitors were used to ascertain adherence, patients were not permitted to use medication container adherence aids. The intervention involved 1 pharmacist and a single study site that served a large, indigent, inner-city population of patients. Because the intervention had several components, intervention effects could not be attributed to a single component. Conclusions: A pharmacist intervention for outpatients with heart failure can improve adherence to cardiovascular medications and decrease health care use and costs, but the benefit probably requires constant intervention because the effect dissipates when the intervention ceases.

Original languageEnglish
Pages (from-to)714-725
Number of pages12
JournalAnnals of Internal Medicine
Volume146
Issue number10
StatePublished - May 15 2007

Fingerprint

Medication Adherence
Pharmacists
Heart Failure
Health Care Costs
Hospital Emergency Service
Electronic Prescribing
Health Literacy
Pharmaceutical Services
Primary Care Physicians
Emergency Medical Services
Poverty
Patient Compliance
Ambulatory Care
Patient Satisfaction
Cost-Benefit Analysis
Prescriptions
Appointments and Schedules
Outpatients
Randomized Controlled Trials
Quality of Life

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pharmacist intervention to improve medication adherence in heart failure : A randomized trial. / Murray, Michael; Young, James; Hoke, Shawn; Tu, Wanzhu; Weiner, Michael; Morrow, Daniel; Stroupe, Kevin T.; Wu, Jingwei; Clark, Daniel; Smith, Faye; Gradus-Pizlo, Irmina; Weinberger, Morris; Brater, D. Craig.

In: Annals of Internal Medicine, Vol. 146, No. 10, 15.05.2007, p. 714-725.

Research output: Contribution to journalArticle

Murray, M, Young, J, Hoke, S, Tu, W, Weiner, M, Morrow, D, Stroupe, KT, Wu, J, Clark, D, Smith, F, Gradus-Pizlo, I, Weinberger, M & Brater, DC 2007, 'Pharmacist intervention to improve medication adherence in heart failure: A randomized trial', Annals of Internal Medicine, vol. 146, no. 10, pp. 714-725.
Murray, Michael ; Young, James ; Hoke, Shawn ; Tu, Wanzhu ; Weiner, Michael ; Morrow, Daniel ; Stroupe, Kevin T. ; Wu, Jingwei ; Clark, Daniel ; Smith, Faye ; Gradus-Pizlo, Irmina ; Weinberger, Morris ; Brater, D. Craig. / Pharmacist intervention to improve medication adherence in heart failure : A randomized trial. In: Annals of Internal Medicine. 2007 ; Vol. 146, No. 10. pp. 714-725.
@article{a834dcb0ab174463883a12b652b36401,
title = "Pharmacist intervention to improve medication adherence in heart failure: A randomized trial",
abstract = "Background: Patients with heart failure who take several prescription medications sometimes have poor adherence to their treatment regimens. Few interventions designed to improve adherence to therapy have been rigorously tested. Objective: To determine whether a pharmacist intervention improves medication adherence and health outcomes compared with usual care for low-income patients with heart failure. Design: Randomized, controlled trial conducted from February 2001 to June 2004. Setting: University-affiliated, inner-city, ambulatory care practice. Patients: 314 low-income patients 50 years of age or older with heart failure confirmed by their primary care physician. Intervention: Patients were randomly assigned to intervention (39{\%} [n = 122]) or usual care (61{\%} [n = 192]) groups and were followed for 12 months. A pharmacist provided a 9-month multi-level intervention, with a 3-month poststudy phase. An interdisciplinary team of investigators designed the intervention to support medication management by patients who have low health literacy and limited resources. Measurements: Primary outcomes were adherence, as measured by using electronic prescription monitors, and exacerbations requiring emergency department care or hospital admission. Secondary outcomes included health-related quality of life, patient satisfaction with pharmacy services, and total direct costs. Results: During the 9-month intervention period, medication adherence was 67.9{\%} and 78.8{\%} in the usual care and intervention groups, respectively (difference, 10.9 percentage points [95{\%} CI, 5.0 to 16.7 percentage points]). However, these salutary effects dissipated in the 3-month postintervention follow-up period, in which adherence was 66.7{\%} and 70.6{\%}, respectively (difference, 3.9 percentage points [CI, -5.9 to 6.5 percentage points]). Medications were taken on schedule 47.2{\%} of the time in the usual care group and 53.1{\%} of the time in the intervention group (difference, 5.9 percentage points [CI, 0.4 to 11.5 percentage points]), but this effect also dissipated at the end of the intervention (48.9{\%} vs. 48.6{\%}, respectively; difference, 0.3 percentage point [CI, -5.9 to 6.5 percentage points]). Emergency department visits and hospital admissions were 19.4{\%} less (incidence rate ratio, 0.82 [CI, 0.73 to 0.93]) and annual direct health care costs were lower ($-2960 [CI, $-7603 to $1338]) in the intervention group. Limitations: Because electronic monitors were used to ascertain adherence, patients were not permitted to use medication container adherence aids. The intervention involved 1 pharmacist and a single study site that served a large, indigent, inner-city population of patients. Because the intervention had several components, intervention effects could not be attributed to a single component. Conclusions: A pharmacist intervention for outpatients with heart failure can improve adherence to cardiovascular medications and decrease health care use and costs, but the benefit probably requires constant intervention because the effect dissipates when the intervention ceases.",
author = "Michael Murray and James Young and Shawn Hoke and Wanzhu Tu and Michael Weiner and Daniel Morrow and Stroupe, {Kevin T.} and Jingwei Wu and Daniel Clark and Faye Smith and Irmina Gradus-Pizlo and Morris Weinberger and Brater, {D. Craig}",
year = "2007",
month = "5",
day = "15",
language = "English",
volume = "146",
pages = "714--725",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "10",

}

TY - JOUR

T1 - Pharmacist intervention to improve medication adherence in heart failure

T2 - A randomized trial

AU - Murray, Michael

AU - Young, James

AU - Hoke, Shawn

AU - Tu, Wanzhu

AU - Weiner, Michael

AU - Morrow, Daniel

AU - Stroupe, Kevin T.

AU - Wu, Jingwei

AU - Clark, Daniel

AU - Smith, Faye

AU - Gradus-Pizlo, Irmina

AU - Weinberger, Morris

AU - Brater, D. Craig

PY - 2007/5/15

Y1 - 2007/5/15

N2 - Background: Patients with heart failure who take several prescription medications sometimes have poor adherence to their treatment regimens. Few interventions designed to improve adherence to therapy have been rigorously tested. Objective: To determine whether a pharmacist intervention improves medication adherence and health outcomes compared with usual care for low-income patients with heart failure. Design: Randomized, controlled trial conducted from February 2001 to June 2004. Setting: University-affiliated, inner-city, ambulatory care practice. Patients: 314 low-income patients 50 years of age or older with heart failure confirmed by their primary care physician. Intervention: Patients were randomly assigned to intervention (39% [n = 122]) or usual care (61% [n = 192]) groups and were followed for 12 months. A pharmacist provided a 9-month multi-level intervention, with a 3-month poststudy phase. An interdisciplinary team of investigators designed the intervention to support medication management by patients who have low health literacy and limited resources. Measurements: Primary outcomes were adherence, as measured by using electronic prescription monitors, and exacerbations requiring emergency department care or hospital admission. Secondary outcomes included health-related quality of life, patient satisfaction with pharmacy services, and total direct costs. Results: During the 9-month intervention period, medication adherence was 67.9% and 78.8% in the usual care and intervention groups, respectively (difference, 10.9 percentage points [95% CI, 5.0 to 16.7 percentage points]). However, these salutary effects dissipated in the 3-month postintervention follow-up period, in which adherence was 66.7% and 70.6%, respectively (difference, 3.9 percentage points [CI, -5.9 to 6.5 percentage points]). Medications were taken on schedule 47.2% of the time in the usual care group and 53.1% of the time in the intervention group (difference, 5.9 percentage points [CI, 0.4 to 11.5 percentage points]), but this effect also dissipated at the end of the intervention (48.9% vs. 48.6%, respectively; difference, 0.3 percentage point [CI, -5.9 to 6.5 percentage points]). Emergency department visits and hospital admissions were 19.4% less (incidence rate ratio, 0.82 [CI, 0.73 to 0.93]) and annual direct health care costs were lower ($-2960 [CI, $-7603 to $1338]) in the intervention group. Limitations: Because electronic monitors were used to ascertain adherence, patients were not permitted to use medication container adherence aids. The intervention involved 1 pharmacist and a single study site that served a large, indigent, inner-city population of patients. Because the intervention had several components, intervention effects could not be attributed to a single component. Conclusions: A pharmacist intervention for outpatients with heart failure can improve adherence to cardiovascular medications and decrease health care use and costs, but the benefit probably requires constant intervention because the effect dissipates when the intervention ceases.

AB - Background: Patients with heart failure who take several prescription medications sometimes have poor adherence to their treatment regimens. Few interventions designed to improve adherence to therapy have been rigorously tested. Objective: To determine whether a pharmacist intervention improves medication adherence and health outcomes compared with usual care for low-income patients with heart failure. Design: Randomized, controlled trial conducted from February 2001 to June 2004. Setting: University-affiliated, inner-city, ambulatory care practice. Patients: 314 low-income patients 50 years of age or older with heart failure confirmed by their primary care physician. Intervention: Patients were randomly assigned to intervention (39% [n = 122]) or usual care (61% [n = 192]) groups and were followed for 12 months. A pharmacist provided a 9-month multi-level intervention, with a 3-month poststudy phase. An interdisciplinary team of investigators designed the intervention to support medication management by patients who have low health literacy and limited resources. Measurements: Primary outcomes were adherence, as measured by using electronic prescription monitors, and exacerbations requiring emergency department care or hospital admission. Secondary outcomes included health-related quality of life, patient satisfaction with pharmacy services, and total direct costs. Results: During the 9-month intervention period, medication adherence was 67.9% and 78.8% in the usual care and intervention groups, respectively (difference, 10.9 percentage points [95% CI, 5.0 to 16.7 percentage points]). However, these salutary effects dissipated in the 3-month postintervention follow-up period, in which adherence was 66.7% and 70.6%, respectively (difference, 3.9 percentage points [CI, -5.9 to 6.5 percentage points]). Medications were taken on schedule 47.2% of the time in the usual care group and 53.1% of the time in the intervention group (difference, 5.9 percentage points [CI, 0.4 to 11.5 percentage points]), but this effect also dissipated at the end of the intervention (48.9% vs. 48.6%, respectively; difference, 0.3 percentage point [CI, -5.9 to 6.5 percentage points]). Emergency department visits and hospital admissions were 19.4% less (incidence rate ratio, 0.82 [CI, 0.73 to 0.93]) and annual direct health care costs were lower ($-2960 [CI, $-7603 to $1338]) in the intervention group. Limitations: Because electronic monitors were used to ascertain adherence, patients were not permitted to use medication container adherence aids. The intervention involved 1 pharmacist and a single study site that served a large, indigent, inner-city population of patients. Because the intervention had several components, intervention effects could not be attributed to a single component. Conclusions: A pharmacist intervention for outpatients with heart failure can improve adherence to cardiovascular medications and decrease health care use and costs, but the benefit probably requires constant intervention because the effect dissipates when the intervention ceases.

UR - http://www.scopus.com/inward/record.url?scp=34250183860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250183860&partnerID=8YFLogxK

M3 - Article

C2 - 17502632

AN - SCOPUS:34250183860

VL - 146

SP - 714

EP - 725

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 10

ER -